Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7386769 | 7849451 | F | 7386769-5 | 20110218 | 20110323 | 20110331 | PER | CA-JNJFOC-20110300332 | CENTOCOR ORTHO BIOTECH INC. | 70 | YR | M | Y | 71 | KG | 20110331 | MD | CANADA |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7386769 | 1016138914 | C | PREDNISONE | 2 | ORAL | ||||||
| 7386769 | 1016138917 | C | FOLIC ACID | 1 | ORAL | ||||||
| 7386769 | 1016138919 | C | CRESTOR | 1 | ORAL | ||||||
| 7386769 | 1016138918 | C | FINASTERIDE | 1 | ORAL | ||||||
| 7386769 | 1016138920 | C | METAMUCIL-2 | 1 | ORAL | ||||||
| 7386769 | 1016138921 | C | SURFAK | 2 | ORAL | ||||||
| 7386769 | 1016138915 | C | EXTRA STRENGTH TYLENOL | 1 | ORAL | ||||||
| 7386769 | 1016138911 | SS | GOLIMUMAB | 2 | SUBCUTANEOUS | 009925 | |||||
| 7386769 | 1016138912 | SS | METHOTREXATE | 1 | ORAL | ||||||
| 7386769 | 1016138916 | C | DIDROCAL | 2 | ORAL | ||||||
| 7386769 | 1016138910 | PS | GOLIMUMAB | 2 | SUBCUTANEOUS | ||||||
| 7386769 | 1016138913 | C | METHOTREXATE | 1 | ORAL | ||||||
| 7386769 | 1016138922 | C | HYDROCHLOROTHIAZIDE | 1 | ORAL |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 7386769 | 1016138912 | RHEUMATOID ARTHRITIS |
| 7386769 | 1016138910 | RHEUMATOID ARTHRITIS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 7386769 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 7386769 | GASTRIC CANCER |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |